would be required for further investigation.
Cognitive studies have often been based on small samples (Bornstein et al, 1985; Rosseffi et a!, 1987) , or tests of doubtful utility (Scheinberg et a!, 1968; Gouse, 1975; Tarter et a!, 1987), or both (Knehr & Bean, 1956; Hayek et a!, 1973) . A problem in selection of instruments has been failure to allow for impairment of motor per
formance. This difficulty is apparent in two studies from the Mayo Clinic. The first (Goldstein et al, 1968) seemed to identify some mild impairments and slight improvement in test scores after treatment.
However, a later study (Davis & Goldstein, 1974) , using more extensive and sophisticated testing, found impaired motor function and co-ordination but no deficits in higher mental processes. Medalia et a! (1988) No control group was recruited, for two main reasons: first, difficulty in defining appropriate controls; and, second, the internal structure of the data would allow adequate comparisons to be made. In other words, the sample could be used to provide its own internal controls to test specific hypotheses.
Data collection
A clinical protocol was designed to explore aspects of neurological, psychiatric and psychological functioning.
General clinical information and biochemical data were also obtained.
Selection of instruments was influenced by fmdings from the retrospective study. The original design was to include the Present State Examination (PSE; Wing eta!, 1974), but it was unsuitable for two reasons: because of its prepon derance of psychosis items (extremely uncommon in the series (Dening & Berrios, 1989) ) and its relatively inflexible behaviour scales; and for the more practical reason that a place on a recommended training course could not be found at the right time.
Neurologicalsymptomatologywasassessedby meansof the Webster Parkinson's Disease Rating Scale (Webster, 1968; cited by Marsden & Schachter, 1981) and the North Western University Disability Scale (NWU; Canter et a!, 1961). Severity of dysarthria was assessed using the intelligibility subscale of the Frenchay Dysarthria Scale (Enderby, 1983 Overall clinical condition was rated by means of the
Global Assessment Scale (GAS; Endicott eta!, 1976) and level of psychotropic medication by an extended version of Summers' (1978) Drug Risk Number (DRN).
Inter-rater reliability
Limited reliability studies were performed by two raters, TRD and a medical student who had received training in the use of the rating scales. Emphasis was on reliable rating of the psychiatric scales. Cohen's kappa (Spitznagel & Helzer, 1985) was used for dichotomic variables (i.e. presence or absence of symptoms on CPRS and personality traits on PAS).
Data management
All cases were examined by TRD. Information was transferred to an IBM AT personal computer for statistical analysis using the SPSSâ€"PC + package (SPSS, 1986) . Scores from rating scales were either used as global scores or else broken down into subscales on an heuristic basis. Missing data were managed by clinical completion (Tabachnick & Fidel, 1983 produce a â€˜¿ non-depressive' psychopathology score. The PAS data were subjected to factor analysis. Factor scores for each subject were generated by addition of scores on those variables significantly loading on to the inter preted factors, a recognised procedure, despite limitations (Tabachnick & Fidell, 1983) . The simplifiedvariables thus obtained were assembledinto a correlational matrix. To examine the underlying structure of the data, exploratory factor analysis was performed, using the Principal Components method with Varimax rotation. Factors extracted were interpreted if eigenvalues were greater than 1.0, and if the factor contained at least three variables with loadings of 0.4 or more.
Tests for causal associationswerecarried out. Discriminant function analysis(Wilks' method) was used to test the classifi catory power of clinical variables with respect to splitting variables which could readily be dichotomised (e.g. good outcome, GHQ caseness,presence/absenceof depressive symptoms, â€˜¿ psychopathy'). The stepwisemethod of multiple regression was used to examine continuous variables.
Results
In all, 31 patients were entered in the study. Descriptive statistics are summarised in Tables I and II A fullspectrumof illnesswasencountered,from patients mute and bedridden to others who had never been symptomatic. Nevertheless, as the majority had been on treatment for some time, the sample was biased in terms of relative good health compared with many others. Among neurological symptoms, dysarthria was the commonest, with only seven subjects attaining the minimum score on the Frenchay scale, consistent with our earlier study (Dening & Berrios, 1989) .It is, however, possiblethat observer sensitivity for dysarthria may be greater than for bradykinesia or rigidity. Quite noticeable was the persistence of relatively minor speech and other deficits, often despite years of therapy; thus presumably the result of permanent damage.
As the sample was biased in the direction of relative good health, the levelof psychopathology identifiedmay have been less than that to be expected in cases of acute illness. Never theless, there was again a range of severity from normal to about the level of psychiatric in-patient status. Ten indivi duals (32%) were GHQ â€˜¿ cases', with four scores of 20 or more. On personality assessment, 16 subjects of the 28 assessed (57%) were rated as abnormal (rating of 4 or more) on at least one item. The method used to create a Depression subscale from the CPRS can be questioned, but the 12items employed were similar to those used in other studies of depressive symptoms using this instrument (e.g. Montgomery
eta!,1978). No psychotic symptomswereobserved.
In general, cognitive impairments were not severe. Only four cases scored below the threshold on the Mini-Mental State.
1. Mean duration of treatment 9.85 (s.d. 5.9) years. Most scores on the Benton test fell within the normal range. Similarly, the mean value of d', an index of memory efficiency, was higher in this cohort than in the control group used with a similar task in another study (Miller& Lewis,1977) .However,it should be noted that the average age of those normal controls was greater than that of the WD sample. The mean value for j@, a measure of willingness to guess, fell midway between the values of the normal controls and the depressed experi mental group in the Miller & Lewis study (1.74 and 3.51 respectively).
Age of patients was not significantly related to any other variable except duration of treatment (P< 0.01). Few differences between the sexes emerged, except that males had higher haemoglobin concentrations (P<0.02). A positive family history of WD was associated with less neurological symptomatology (P< 0.001) but no other significant differences. This finding is in keeping with our earlier study; the explanation being that many cases are identified by screening of asymptomatic family members who are then treated before impairments can develop.
Duration of treatment correlated with low levels of neurological symptoms (P< 0.001), high platelet counts (P<0.00l) and low urinary copper output (P<0.01). Although psychotropic medication was also recorded, only a minority of patients were on such treatment, and useful comparisons could not be made. Measurement of spontaneous blink rate, a marker for central dopaminergic function, did not prove informative in this study, although reduced blink rate was correlated with bradykinesia and facial immobility, variablesassociatedwitha Parkinsonianclinical picture.
Factor analysis of the PAS data yielded four factors. The first factor contained nine traits, including impulsiveness, irresponsibility, aggression and (lack of) conscientiousness, and was labelled as â€˜¿ psychopathic'. The third factor comprised introspection, callousness and aloofness, and was named â€˜¿ schizoid'. The second and fourth factors were less readily identifiable, but as each seemed to contain neurotic symptoms, they were labelled â€˜¿ neurotic 1' and â€˜¿ neurotic 2'. Important correlations using the modified variables are shown in Table III . The â€˜¿ schizoid'factor was not significantly related to any other variable; and the â€˜¿ neurotic 1' factor exhibited associations with neurological symptoms. Principal-components analysis of the modified variables yielded four factors: â€˜¿ neurological', â€˜¿ cognitive', â€˜¿ hepatic/ depressive', and â€˜¿ psychiatric' (Table IV) .
Discriminant function analysis showed that cases with good outcome (GAS of 70 or more) were classified at the rate of 87% by either Webster or CPRS score. GHQ caseness at the recognised cut-off of 3/4 (Goldberg scoring) was classified at a rate of 84% by two variables â€"¿ impaired walking (NWU) and serum level of alanine aminotransferase (ALT). â€˜¿ Psychopathic personality dis order', defined at a threshold score of 9/10 on the psychopathic factor of the PAS, was classified at a rate of 79Â°lo by dysarthria alone. Two items from the â€˜¿ Depressive' subscale of the CPRS, pessimism and sadness,
were classified both at a rate of 81% by impaired walking (NWU) and abnormal gait (Webster), respectively.
Abnormal serum valuesof ALT (Addenbrooke's normal range: females 0â€"25 lU/l; males 0â€"38 lU/I) were classified at a rate of 81% by the variables inability to feel, reduced sleep, and fatigue. Using regression analysis, impaired walking accounted for 39.9% of the variance in the depression score derived from the CPRS, and for 32.7% of the variance in scores on the Benton visuospatial test. Dysarthria and psycho pathic personality together accounted for 43.2% of variance in Mini-Mental State scores; and sadness for 26.2% of that in $ (criterion measure of signal detection test). No neurological or psychiatric variable predicted d' to any significant extent. are more prepared to be followed up. Secondly, a majority of patients had received chelating agents for a considerable time, with several effects: (a) relatively high mean age; (b) relative lack of acute, in particular hepatic, symptoms or biochemical disturbance; (c) bias towards chronic, neurological symptoms or else towards a symptom-free state. Overall, patients in the sample were not severely ill:
mean GAS was over 70, corresponding to â€oe¿ minimal symptoms. . . but no more than slight impairment in functioningâ€• (Endicott eta!, 1976) . Caution must therefore be exercised in extending the results of this survey to the entire population of cases of WD. On the other hand, the sample, a consecutive series of attenders, was typical of the proportion of new and follow-up cases which might be seen by a specialist clinic, carrying a full range of symptoms (and variance).
A problem in using batteries of instruments is that items may overlap, leading to inflated correlations. For example, dysarthria was rated on the Webster, NWU and CPRS scales, aswellasby theFrenchay scale. Other motor symptoms were also recorded on more than one scale. By the same token the GAS, derived from clinical symptomatology, proved of limited value. As mentioned above, various methods were used to eliminate redundancy. Four neur ological variables were retained, each representing a component of the disease picture: bradykinesia, tremor, gait disturbance (ataxia) and dysarthria.
Psychiatric items were divided according to the hypo thesis that some would reflect affective path ology. Personality data were subjected to a more formal division, by factor analysis, since there was also interest in making comparisons with other studies.
The number of variables examined is relatively large in proportion to the sample size, and the statistical techniques employed may be at the limits of their power. Some findings must therefore be treated with caution. Nonetheless, the main results appear clinically relevant, and some replicate earlier findings from retrospective data.
Neurological symptomatology
The neurological symptoms were highly intercor related, but different symptoms were associated in different ways with other manifestations. For example, tremor was not related to psychopathology or cognition, bradykinesia was closely associated with psychopathy, and gait disorder was related to depression and cognition and to abnormal personality. (Miller & Lewis, 1977) . Higher 13 in depressed subjects may reflect a conservative guessing strategy.
Psychiatric symptoms and personality
In the factor analysis of the PAS scores of the 28 cases for whom the schedule was completed, it could be argued that too many variables were used for the number of cases. However, the factor structure obtained was not dissimilar to that described by Tyrer & Alexander (1979) . There are conceptual problems in examining personality characteristics in patients with brain disease, especially if such subjects are relatively young at onset of illness. Also, personality inventories seem to be influenced by mental state (Griffiths, 1970) . To some extent this can be circumvented by use of an informant, but, if the illness is chronic, mental state still intrudes. That this process has operated in this study is suggested by the associations between the neurotic 2 personality factor and measures of depressive symptoms.
Probably the most important finding of this study is the prospective replication of our earlier con clusion that disorders of behaviour and personality are significantly related to neurological symptoms, especially dysarthria, bradykinesia and rigidity. These were strong correlations between the psychopathic personality factor, non-depressive psychopathology on CPRS and these neurological measures. In addition, psychopathy and neurology loaded on to the same factor. Dysarthria was the most powerful single predictor of psychopathy when discriminant function analysis was applied. It is evident that the psychopathology of WD is not homogeneous, since syndromes with different correlates can be identified.
The data regarding personality and behavioural abnormalities are strongly suggestive of an organic basis for these disorders. Certainly a â€˜¿ reactive' hypothesis fails to explain why such disorders are associated with some neurological symptoms and not with others (e.g. tremor).
The data also suggest a relationship between metabolic disorder, presumably due to hepatic dysfunction, and depressive symptoms. Serum levels of ALT and protein were correlated significantly with the depression score of the CPRS, and in particular with inability to feel, reduced sleep and loss of interest in sex. Correlations with GHQ score were also positive but just short of statistical significance (e.g. ALT and GHQ: r=0.37). On factor analysis, these biochemical variables loaded on to the same factor as GHQ and depression score. With dis criminant function analysis, ALT proved one of the most powerful predictors of GHQ â€˜¿ caseness'. However, it would appear that much of the variance of depressive symptomatology was not explained by hepatic disease, as a second depressive factor was extracted, which also contained the neurotic 2 personality factor and the 13criterion measure from the Signal Detection Memory Test, neither of which were at all correlated with hepatic disorder. Correlations were also found between depression and some of the neurological items, although such associations were less striking than those between personality and neurological variables.
Statistical evidence of a contribution by hepatic disease to depression in WD is a new finding, but it should be interpreted with caution, as only three or four patients had significant active hepatic disease; with just one patient, on the verge of liver failure, having severe hepatic symptoms. It is also possible that the biochemical markers used as evidence of hepatic dysfunction were of limited validity.
The mechanism relating depression and hepatic disease is unclear: there may be a simple connection between having a metabolic disorder and feeling unwell, there may be a â€˜¿ reactive' depression to the seriousness of the disease, or there may be a more complex process whereby depression leads to meta bolic abnormality through non-compliance with therapy or some other intervening variable. Perhaps what has been labelled as depression is wrongly named, and should be thought of as â€˜¿ malaise' or â€˜¿ weariness' (i.e. it is a behavioural phenocopy of depression).
Nevertheless, the relationship of indices of hepatic disease and symptoms commonly recognised in de pression is an important and robust finding. The failure of the retrospective study to indicate this relationship may be due to two factors. Firstly, the threshold for recognition of depression in that study may have been high, with failure to identify milder cases. In addition, clinical and biochemical evalu ations may have been performed at different points in time, resulting in a desyncbronisation of depressive and hepatic features. In this prospective study, clinical and biochemical testing were simultaneous.
